MCID: GGR001
MIFTS: 40

Geographic Tongue malady

Categories: Rare diseases, Gastrointestinal diseases, Oral diseases

Aliases & Classifications for Geographic Tongue

About this section

Aliases & Descriptions for Geographic Tongue:

Name: Geographic Tongue 10 45 12
Glossitis, Benign Migratory 36 65
Benign Migratory Glossitis 10 45
Glossitis Areata Exfoliativa 10
 
Erythema Chronicum Migrans 65
Ectopic Geographic Tongue 45
Pityriasis Linguae 10
Erythema Migrans 45

Classifications:



External Ids:

Disease Ontology10 DOID:1455
ICD1027 A26.0, K14.1
ICD9CM29 529.1
MeSH36 D005929
NCIt42 C84588
UMLS65 C0017677, C0014740

Summaries for Geographic Tongue

About this section
NIH Rare Diseases:45 Geographic tongue is a condition that causes chronic and recurrent lesions on the tongue that resemble psoriasis of the skin. it is characterized by pink to red, slightly depressed lesions with irregular, elevated, white or yellow borders. the lesions may also occur in the mucosa of the mouth and labia; this condition is called "areata migrans" because these lesions typically disappear from one area and show up in another. the tongue is normally covered with tiny, pinkish-white bumps (papillae), which are actually short, fine, hair-like projections. with geographic tongue, patches on the surface of the tongue are missing papillae and appear as smooth, red "islands," often with slightly raised borders. these patches (lesions) give the tongue a map-like, or geographic, appearance. in most cases there are no symptoms but sometimes it is painful when inflamed. the cause of this condition is unknown. many researchers think it is linked with psoriasis, but more research is needed to better understand the connection. also, hereditary and environmental factors may be involved. the condition is benign and localized, generally requiring no treatment except reassurance. if painful, it may be treated with steroid gels or antihistamine mouth rinses.  last updated: 4/14/2016

MalaCards based summary: Geographic Tongue, also known as glossitis, benign migratory, is related to fissured tongue and lyme disease. An important gene associated with Geographic Tongue is IL36RN (Interleukin 36 Receptor Antagonist), and among its related pathways are Viral carcinogenesis and IL12-mediated signaling events. Affiliated tissues include tongue, skin and testes.

Disease Ontology:10 An atrophic glossitis that is characterized as an inflammatory condition of the mucous membrane of the tongue, usually on the dorsal surface.

Wikipedia:68 Geographic tongue, also known by several other terms,[note 1] is an inflammatory condition of the mucous... more...

Related Diseases for Geographic Tongue

About this section

Diseases related to Geographic Tongue via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 139)
idRelated DiseaseScoreTop Affiliating Genes
1fissured tongue11.6
2lyme disease10.6
3periventricular leukomalacia10.5HLA-A, HLA-B
4postinfectious encephalomyelitis10.5HLA-A, HLA-B
5hydromyelia10.5HLA-A, HLA-B
6retinitis10.5HLA-A, HLA-B
7anthracosis10.5HLA-A, HLA-B
8undetermined early-onset epileptic encephalopathy10.5HLA-A, HLA-B
9intermediate uveitis10.5HLA-A, HLA-B
10acquired thrombocytopenia10.5HLA-A, HLA-B
11estrogen excess10.4HLA-A, HLA-B
12malignant hypertension10.4HLA-A, HLA-B
13noonan-like/multiple giant cell lesion syndrome10.4HLA-A, HLA-B
14rectum sarcomatoid carcinoma10.4AKTIP, HLA-G
15dental pulp disease10.4AKTIP, HLA-G
16impetigo10.4HLA-C, IL36RN
17hypercementosis10.4HLA-B, IL2RA
18cryptosporidiosis10.3HLA-A, HLA-B
19juvenile pilocytic astrocytoma10.3HLA-A, HLA-B
20spondyloarthropathy 110.3EPHX1, HLA-A, HLA-B
21idiopathic juxtafoveal retinal telangiectasia10.3HLA-B, HLA-DQB1
22demyelinating disease10.3HLA-A, HLA-B, IL2RA
23bk-virus nephropathy10.3HLA-A, HLA-C
24anthracosilicosis10.3HLA-A, HLA-B, HLA-G
25iridocyclitis10.3HLA-A, HLA-B, HLA-C
26metanephric adenoma10.3HLA-B, HLA-DQB1
27lacrimal duct obstruction10.3HLA-A, HLA-B, HLA-C
28bronchiolitis10.3HLA-B, IL6
29glycogen storage disease iiia10.3HLA-A, HLA-B, HLA-C
30lactocele10.3HLA-A, HLA-B, HLA-C
31villonodular synovitis10.3HLA-A, HLA-B, HLA-C
32disseminated chorioretinitis10.2HLA-A, HLA-B, HLA-C
33peritonitis10.2
34choroid spindle cell melanoma10.2HLA-A, HLA-B, NME1
35gonococcal iridocyclitis10.2HLA-A, HLA-B, TNFRSF10B
36dermatitis herpetiformis10.2IL36RN, IL6
37blue color blindness10.2HLA-A, HLA-B, TNFRSF10B
38orbit alveolar rhabdomyosarcoma10.2HLA-A, HLA-B
39leprosy 410.2HLA-B, HLA-C, IL36RN
40subcorneal pustular dermatosis10.2HLA-A, HLA-B, HLA-DQB1
41lymphocytic choriomeningitis10.2HLA-A, HLA-B, HLA-DQB1
42cytoplasmic body myopathy10.2HLA-A, HLA-B, HLA-DQB1
43kernicterus due to isoimmunization10.2HLA-A, HLA-B, HLA-DQB1
44artemis deficiency10.2HLA-A, HLA-B, HLA-DQB1
45artery disease10.2HLA-A, HLA-B, HLA-DQB1
46angioid streaks10.2HLA-A, HLA-DQB1, IL2RA
47glioblastoma10.2
48polyradiculopathy10.1IL2RA, IL6
49miliary tuberculosis10.1HLA-A, HLA-DQB1, IL2RA
50acneiform dermatitis10.1HLA-A, HLA-B, HLA-C, IL36RN

Graphical network of the top 20 diseases related to Geographic Tongue:



Diseases related to geographic tongue

Symptoms for Geographic Tongue

About this section

Drugs & Therapeutics for Geographic Tongue

About this section

Drugs for Geographic Tongue (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxycyclineapproved, investigationalPhase 4219564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
2
Penicillin VapprovedPhase 41687-08-16869
Synonyms:
(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID
(2S,5R,6R)-3,3-DIMETHYL-7-oxo-6-(2-phenoxyacetamido)-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(phenyloxy)acetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
1098-87-9 (mono-hydrochloride salt)
132-98-9
132-98-9 (mono-potassium salt)
147-48-8 (mono-hydrochloride salt)
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carbonyl
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carboxylic acid
3,3-Dimethyl-7-oxo-6-((phenyloxyacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
3,3-dimethyl-6beta-[(phenoxyacetyl)amino]penam-2alpha-carboxylic acid (PIN)
4-27-00-05884 (Beilstein Handbook Reference)
6-Phenoxyacetamidopenicillanic acid
6-phenoxyacetamidopenicillanic acid
87-08-1
AB00514745
AC1L1NHG
AC1Q5QX3
AR-1H6492
Acipen V
Apocillin
Apopen
BRD-K43966364-237-02-2
BRN 0096259
BSPBio_002185
Beepen-VK
Beromycin
Beromycin, Penicillin
Berromycin, Penicillin
Betapen-VK
Bio-0630
C08126
C16H18N2O5S
CCRIS 752
CHEBI:27446
CHEBI:53706
CHEMBL615
CID6869
Calcipen
Compocillin V
Crystapen V
D05411
DB00417
DB08415
Distaquaine V
DivK1c_000779
EINECS 201-722-0
Eskacillian V
Eskacillin V
Fenacilin
Fenospen
Fenossimetilpenicillina
Fenossimetilpenicillina [DCIT]
Fenossimetilpenicillina [Dcit]
Fenoximetilpenicilina
Fenoximetilpenicilina [INN-Spanish]
Fenoxymethylpenicillin
Fenoxypen
HSDB 6314
IDI1_000779
KBio1_000779
KBio2_001487
KBio2_004055
KBio2_006623
KBio3_001685
KBioGR_000944
KBioSS_001487
LS-1861
 
MLS001304105
Meropenin
MolPort-002-515-462
NCGC00159342-02
NINDS_000779
Oracillin
Oratren
Ospen
P-Mega-Tablinen
PNV
PV
PVA
Pen-Oral
Pen-V
Pen-vee
Penapar-Vk
Penicillin Phenoxymethyl
Penicillin V (USP)
Penicillin V Potasium
Penicillin V Potassium
Penicillin V [USAN]
Penicillin phenoxymethyl
Penicillin v
Penicillin, Phenoxymethyl
Penicillin-Vk
Phenocillin
Phenomycilline
Phenopenicillin
Phenoximethylpenicillinum
Phenoxomethylpenicillin
Phenoxomethylpenicillin potassium
Phenoxymethyl Penicillin
Phenoxymethyl penicillin
Phenoxymethylenepenicillinic Acid
Phenoxymethylenepenicillinic acid
Phenoxymethylpenicillin
Phenoxymethylpenicillin (INN)
Phenoxymethylpenicillin Potassium
Phenoxymethylpenicilline
Phenoxymethylpenicilline [INN-French]
Phenoxymethylpenicillinic Acid
Phenoxymethylpenicillinic Acid Potassium Salt
Phenoxymethylpenicillinic acid potassium salt
Phenoxymethylpenicillinum
Phenoxymethylpenicillinum [INN-Latin]
Robicillin
Rocilin
SMR000539431
SPBio_000389
Spectrum2_000495
Spectrum3_000543
Spectrum4_000472
Spectrum5_001409
Spectrum_001007
Stabicillin
UNII-Z61I075U2W
V-Cil
V-Cillin
V-Cillin (TN)
V-Cillin K
V-Cylina
V-Cyline
V-Tablopen
V-cillin
Vebecillin
Vegacillin
acipen-v
penicillin v
phenoxomethylpenicillanyl
phenoxomethylpenicillin
phenoxymethylpenicillanyl
phenoxymethylpenicillinic acid
3
CefuroximeapprovedPhase 44655268-75-25361202, 5479529
Synonyms:
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester)
153012-39-6
3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid
55268-75-2
56238-63-2
AC-15028
AC-4539
AC1NUIFB
AC1Q41FS
Anaptivan
BIDD:GT0619
BPBio1_001033
BRD-K02733959-236-02-8
BRN 5783190
BSPBio_000939
Biociclin
Biofuroksym
Bioxima
C06894
C08108
C16H15N4O8S.Na
C16H16N4O8S
C4417_FLUKA
C4417_SIGMA
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
CEFUROXIME SODIUM
CHEBI:3515
CHEMBL1436
CID5479529
CID6523269
CPD0-2069
CXM
Cefofix
Ceftin
Cefumax
Cefurex
Cefuril
Cefuroxim
Cefuroxim AJ
Cefuroxim Fresenius
Cefuroxim Genericsn
Cefuroxim Hexal
Cefuroxim Lilly
Cefuroxim MN
Cefuroxim Norcox
Cefuroxim Norcox [inj.]
Cefuroxim curasan
Cefuroxima Fabra
Cefuroxima Richet
Cefuroxime
Cefuroxime (TN)
 
Cefuroxime (USAN/INN)
Cefuroxime [USAN:BAN:INN]
Cefuroxime [USAN:INN:BAN]
Cefuroxime for Injection and Dextrose for Injection in Duplex Container
Cefuroxime sodium (JP15/USP)
Cefuroxime sodium [USAN:BAN:JAN]
Cefuroxime sodium salt
Cefuroximine
Cefuroximo
Cefuroximo [INN-Spanish]
Cefuroximum
Cefuroximum [INN-Latin]
Cephuroxime
Cetroxil
Cetroxil [inj.]
Colifossim
Curocef
Curoxim
Curoxima
Curoxime
D00262
D00915
EINECS 259-560-1
EINECS 260-073-1
Froxal
Froxal [inj.]
Furoxil
KEFUROX IN PLASTIC CONTAINER
KS-1040
Kesint
Ketocef
LS-149936
LS-2226
Lifurox
Medoxim
MolPort-002-885-814
MolPort-005-938-003
Prestwick3_000720
Sharox
Sharox [inj.]
Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester)
Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium cefuroxime
Spectrazolr
UNII-O1R9FJ93ED
UNII-R8A7M9MY61
Ultroxim
ZINACEF IN PLASTIC CONTAINER
Zinacef
Zinacef (TN)
Zinacef Danmark
Zinacef danmark
Zinnat [inj.]
cefuroxime
cefuroxime na
cefuroximesodium
4
AmoxicillinapprovedPhase 439126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Extended-release
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
Augmentinxr
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
 
BRL-2333
BSPBio_000453
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
5cefuroxime axetilPhase 446
6penicillinsPhase 492
7Antiprotozoal AgentsPhase 41730
8Anti-Bacterial AgentsPhase 4, Phase 1, Phase 29140
9Antiparasitic AgentsPhase 41854
10Antibiotics, AntitubercularPhase 4, Phase 1, Phase 25971
11Anti-Infective AgentsPhase 417220
12AntimalarialsPhase 41058
13
Ceftriaxoneapproved11073384-59-55479530, 5361919
Synonyms:
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
104376-79-6
104376-79-6 (di-hydrochloride salt)
73384-59-5
74578-69-1 (di-hydrochloride salt, hemiheptahydrate)
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
AC-1592
AC1NUIFE
Biotrakson
C06683
C18H18N8O7S3
CEFTRIAXONE SODIUM
CHEBI:29007
CHEMBL161
CID5479530
CTRX
Cefatriaxone
Ceftriaxon
Ceftriaxona
Ceftriaxona [INN-Spanish]
Ceftriaxone
 
Ceftriaxone (INN)
Ceftriaxone (TN)
Ceftriaxone [USAN:JAN]
Ceftriaxone intravenous
Ceftriaxone, Disodium Salt
Ceftriaxone, Disodium Salt, Hemiheptahydrate
Ceftriaxonum
Ceftriaxonum [INN-Latin]
Ceftriazone
D07659
DB01212
DRG-0071
EINECS 277-405-6
LS-150031
Longacef
Longaceph
MolPort-005-933-495
Ro 139904
Ro-13-9904
Ro13-9904
Rocefin
Rocephin
Rocephine
UNII-75J73V1629
ceftriaxone
14Antitubercular Agents1061

Interventional clinical trials:

(show all 16)
idNameStatusNCT IDPhase
1Comparing 3 Antibiotic Regimes for Erythema Migrans in General PracticeCompletedNCT01368341Phase 4
2Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological OutcomeCompletedNCT01518192Phase 4
3Xenodiagnosis After Antibiotic Treatment for Lyme DiseaseRecruitingNCT02446626Phase 1, Phase 2
4Duration of Antibiotic Treatment of Erythema MigransCompletedNCT00910715
5Doxycycline in Therapy of Erythema MigransCompletedNCT01475708
6Culture Media for Borrelia Burgdorferi Sensu LatoCompletedNCT02145754
7Searching for Persistence of Infection in Lyme DiseaseCompletedNCT01143558Phase 0
8Cytokines and Chemokines in Erythema MigransRecruitingNCT02147249
9Analysis of Lyme Disease LesionsRecruitingNCT00132327
10Lyme Borreliosis and Early Cutaneous DiagnosticRecruitingNCT02414789
11Borrelia Species in Cutaneous Lyme BorreliosisRecruitingNCT00576082
12A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme DiseaseRecruitingNCT02741609
13The Relationship Between Allergic Rhinitis and Geographic TongueRecruitingNCT01454492
14Antibiotic Treatment of Multiple Erythema MigransActive, not recruitingNCT01163994
15Doxycycline and Ceftriaxone in Suspected Early Lyme NeuroborreliosisNot yet recruitingNCT00942006
16Investigation of Southern Tick-Associated Rash Illness (STARI)TerminatedNCT00358761

Search NIH Clinical Center for Geographic Tongue


Cochrane evidence based reviews: glossitis, benign migratory

Genetic Tests for Geographic Tongue

About this section

Anatomical Context for Geographic Tongue

About this section

MalaCards organs/tissues related to Geographic Tongue:

33
Tongue, Skin, Testes, Liver, Eye, B cells, Endothelial

Animal Models for Geographic Tongue or affiliated genes

About this section

MGI Mouse Phenotypes related to Geographic Tongue:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Geographic Tongue

About this section

Articles related to Geographic Tongue:

(show all 39)
idTitleAuthorsYear
1
Acute motor axonal neuropathy in a child with atypical presentation: a case report. (25621680)
2015
2
Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. (24465927)
2014
3
Provocation of migraine with aura using natural trigger factors. (23345632)
2013
4
Androgenic alopecia in women: an Indian perspective. (24517037)
2013
5
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression. (22009636)
2012
6
11C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastases. (22381780)
2012
7
The regulatory role of microRNA-1187 in TNF-I+-mediated hepatocyte apoptosis in acute liver failure. (22266786)
2012
8
Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. (21275808)
2011
9
Redox regulation of the AMP-activated protein kinase. (21079763)
2010
10
Rituximab inhibits B-cell receptor signaling. (19965664)
2010
11
Pancreatic and Gastric Plasmacytoma Presenting with Obstructive Jaundice, Diagnosed with Endoscopic Ultrasound-Guided Fine Needle Aspiration. (21060710)
2010
12
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis. (20216541)
2010
13
Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles. (20305535)
2010
14
Enzyme-linked immunosorbent assay using glycoprotein and monoclonal antibody for detecting antibodies to vesicular stomatitis virus serotype New Jersey. (19279165)
2009
15
Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease. (18617279)
2009
16
Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2. (19923455)
2009
17
Treatment of unilateral coronal synostosis by endoscopic strip craniectomy or fronto-orbital advancement: Ophthalmologic findings. (19393513)
2009
18
Rosiglitazone for nonalcoholic steatohepatitis. (19013165)
2008
19
Light control of peroxisome proliferation during Arabidopsis photomorphogenesis. (19704562)
2008
20
Small interference RNAs directed against KDR gene inhibit the proliferation of breast cancer cells in vitro and in vivo]. (18177622)
2008
21
Severe receptive language disorder in childhood--familial aspects and long-term outcomes: results from a Scottish study. (17405857)
2007
22
Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile. (17630107)
2007
23
Genomic analysis of Xenopus organizer function. (16756679)
2006
24
SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma. (16762634)
2006
25
Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis. (15286970)
2004
26
Protective role of NF-kappaB1 (p50) in experimental pneumococcal meningitis. (15364010)
2004
27
Arthrosonography of hip and knee joints in the follow up of juvenile rheumatoid arthritis. (12594110)
2003
28
A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites. (11972334)
2002
29
Early immunological defects in comatose patients after acute brain injury. (11354400)
2001
30
Exploratory eye movements to pictures in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder (ADHD). (10197405)
1999
31
Training community voluteers in preventing alcoholism and drug addiction : a basic programme and its impact on certain variables. (21584078)
1997
32
Induced TNF production in vitro as a test for familial Mediterranean fever. (8731564)
1996
33
Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). (7600574)
1995
34
Investigation of the "hangover" effects of an acute dose of alcohol on psychomotor performance. (8333598)
1993
35
Genomic dispersal of the ets gene family during metazoan evolution. (1501883)
1992
36
The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs. (2122961)
1990
37
Antibiotics in suppurative otitis media. (854351)
1977
38
An explanation of eye movements seen in internuclear ophthalmoplegia. (820313)
1976
39
Primary orbital melanoma. (4835051)
1974

Variations for Geographic Tongue

About this section

Expression for genes affiliated with Geographic Tongue

About this section
Search GEO for disease gene expression data for Geographic Tongue.

Pathways for genes affiliated with Geographic Tongue

About this section

Pathways related to Geographic Tongue according to GeneCards Suite gene sharing:

(show top 18)    (show all 19)
idSuper pathwaysScoreTop Affiliating Genes
19.2HLA-A, HLA-B, HLA-C, HLA-G
2
Show member pathways
9.1B2M, HLA-A, IL2RA
3
Show member pathways
9.1B2M, HLA-A, IL2RA
48.8HLA-A, HLA-B, HLA-C, HLA-G, IL2RA
5
Show member pathways
8.7HLA-A, HLA-B, HLA-C, HLA-G, TNFRSF10B
6
Show member pathways
8.6HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G
78.6HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G
88.6HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G
98.6HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G
10
Show member pathways
8.5HLA-A, HLA-B, HLA-C, HLA-G, IL6
118.3B2M, HLA-A, HLA-B, HLA-C, HLA-G
128.3B2M, HLA-A, HLA-B, HLA-C, HLA-G
13
Show member pathways
8.3B2M, HLA-A, HLA-B, HLA-C, HLA-G
14
Show member pathways
8.0B2M, HLA-A, HLA-B, HLA-C, HLA-G
15
Show member pathways
7.8B2M, HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G
167.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G, IL2RA
17
Show member pathways
7.2HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G, IL2RA
18
Show member pathways
6.9B2M, HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G

GO Terms for genes affiliated with Geographic Tongue

About this section

Cellular components related to Geographic Tongue according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1integral component of lumenal side of endoplasmic reticulum membraneGO:00715569.9HLA-C, HLA-DQB1
2cell surfaceGO:00099869.5HLA-A, HLA-B, HLA-C
3ER to Golgi transport vesicle membraneGO:00125078.1B2M, HLA-A, HLA-C, HLA-DQB1, HLA-G

Biological processes related to Geographic Tongue according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1protection from natural killer cell mediated cytotoxicityGO:004227010.6HLA-A, HLA-B
2negative regulation of immune responseGO:005077710.3HLA-G, IL2RA
3negative regulation of T cell proliferationGO:004213010.3HLA-G, IL2RA
4antigen processing and presentation of endogenous peptide antigen via MHC class IGO:001988510.0B2M, HLA-A
5positive regulation of T cell cytokine productionGO:000272610.0B2M, HLA-A
6antibacterial humoral responseGO:00197319.7B2M, HLA-A
7positive regulation of T cell mediated cytotoxicityGO:00019169.7B2M, HLA-A, HLA-B
8interferon-gamma-mediated signaling pathwayGO:00603339.4HLA-A, HLA-B, HLA-C, HLA-G
9defense response to Gram-positive bacteriumGO:00508309.2B2M, HLA-A, IL6
10defense response to Gram-negative bacteriumGO:00508299.2B2M, IL6
11antigen processing and presentationGO:00198829.1HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-G
12inflammatory responseGO:00069549.1IL2RA, IL6, TNFRSF10B
13antigen processing and presentation of peptide antigen via MHC class IGO:00024748.7B2M, HLA-A, HLA-B, HLA-C, HLA-G
14viral processGO:00160328.6B2M, HLA-A, HLA-B, HLA-C

Molecular functions related to Geographic Tongue according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:004260510.0HLA-A, HLA-B

Sources for Geographic Tongue

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet